STMicroelectronics (NYSE:STM) was in the spotlight on Monday as investment firm TD Cowen downgraded the industrial-focused ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

Transocean (NYSE:RIG – Free Report) had its target price cut by TD Cowen from $6.50 to $5.50 in a research note issued to ...

TD Cowen analyst Andrew Kligerman upgraded Arthur J. Gallagher (AJG) to Buy from Hold with a price target of $377, up from $295, following the ...

TD Cowen analyst Phil Nadeau maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report) today. The company’s shares opened ...

Fintel reports that on January 8, 2025, TD Cowen initiated coverage of Axon Enterprise (NasdaqGS:AXON) with a Buy ...

The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

The S&P 500 gained 0.55% to close at 5,975.38. The Nasdaq Composite advanced 1.24% to end at 19,864.98. The Dow Jones ...

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...

Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD Cowen report on the big investment themes of 2025, including shifting ...

Shares of American Airlines surged Monday after brokerages Jefferies and TD Cowen upgraded and raised their price targets on ...

TD Cowen analyst Jeff Osborne initiated coverage of Nextracker (NXT) with a Hold rating and $41 price target The firm likes the company’s management team, portfolio and market presence and sees ...